163 related articles for article (PubMed ID: 33298651)
1. [Acute promyelocytic leukemia recurrence diagnosed due to granulocytic sarcoma of the external auditory canal].
Isshiki T; Yoshizawa Y; Iimura Y; Fukuda K; Suzuki S; Sato Y; Nagasawa T
Rinsho Ketsueki; 2020; 61(11):1590-1594. PubMed ID: 33298651
[TBL] [Abstract][Full Text] [Related]
2. [All-trans retinoic acid/arsenic trioxide combination therapy for a patient with acute promyelocytic leukemia on dialysis].
Nagao R; Hosoba R; Yahagi Y; Gunji T; Uryu H; Hattori D; Momoki M; Yamazaki H
Rinsho Ketsueki; 2019; 60(10):1431-1435. PubMed ID: 31695003
[TBL] [Abstract][Full Text] [Related]
3. Long-term survival in an acute promyelocytic leukemia patient with recurrent granulocytic sarcomas: A case report.
Zhou X; Li C
Medicine (Baltimore); 2021 Apr; 100(14):e25257. PubMed ID: 33832087
[TBL] [Abstract][Full Text] [Related]
4. CNS relapses of acute promyelocytic leukemia after all-trans retinoic acid.
Burry LD; Seki JT
Ann Pharmacother; 2002 Dec; 36(12):1900-6. PubMed ID: 12452754
[TBL] [Abstract][Full Text] [Related]
5. [Extramedullary relapse in the external auditory canal in a patient with acute promyelocytic leukemia treated with all-trans retinoic acid and autologous peripheral blood stem cell transplantation].
Yagita M; Onishi R; Yamagata N; Shimazaki C; Kudoh H; Kobayashi M; Hikiji K; Konaka Y
Rinsho Ketsueki; 1998 Sep; 39(9):709-15. PubMed ID: 9796408
[TBL] [Abstract][Full Text] [Related]
6. Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation. APL Study Group. Acute promyelocytic leukemia.
Thomas X; Dombret H; Cordonnier C; Pigneux A; Gardin C; Guerci A; Vekhoff A; Sadoun A; Stamatoullas A; Fegueux N; Maloisel F; Cahn JY; Reman O; Gratecos N; Berthou C; Huguet F; Kotoucek P; Travade P; Buzyn A; de Revel T; Vilque JP; Naccache P; Chomienne C; Degos L; Fenaux P
Leukemia; 2000 Jun; 14(6):1006-13. PubMed ID: 10865965
[TBL] [Abstract][Full Text] [Related]
7. Relapse in the external auditory canal of acute promyelocytic leukemia after treatment with all-trans retinoic acid.
Tobita T; Shinjyo K; Yanagi M; Takeshita A; Ohnishi K; Ohno R
Intern Med; 1997 Jul; 36(7):484-6. PubMed ID: 9240497
[TBL] [Abstract][Full Text] [Related]
8. Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy.
Zhou GB; Zhang J; Wang ZY; Chen SJ; Chen Z
Philos Trans R Soc Lond B Biol Sci; 2007 Jun; 362(1482):959-71. PubMed ID: 17317642
[TBL] [Abstract][Full Text] [Related]
9. [Acute promyelocytic leukemia: state-of-the-art management].
Asou N
Rinsho Ketsueki; 2018; 59(6):725-734. PubMed ID: 29973452
[TBL] [Abstract][Full Text] [Related]
10. External auditory canal and middle ear relapse of acute promyelocytic leukemia treated with arsenic trioxide: case report and review of the literature.
Lafayette TC; Coser VM; Brûlé AO; Coser PL; Pereira WV
J Pediatr Hematol Oncol; 2010 Apr; 32(3):229-32. PubMed ID: 20186102
[TBL] [Abstract][Full Text] [Related]
11. Two successful deliveries of healthy children by a young woman diagnosed and treated during induction and relapsed therapy for acute promyelocytic leukemia.
Dang CC; Guan YK; Lau NS; Chan SY
J Oncol Pharm Pract; 2020 Dec; 26(8):2034-2037. PubMed ID: 32279594
[TBL] [Abstract][Full Text] [Related]
12. Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial.
Zhu HH; Wu DP; Du X; Zhang X; Liu L; Ma J; Shao ZH; Ren HY; Hu JD; Xu KL; Wang JW; Song YP; Fang MY; Li J; Yan XY; Huang XJ
Lancet Oncol; 2018 Jul; 19(7):871-879. PubMed ID: 29884593
[TBL] [Abstract][Full Text] [Related]
13. A new transcriptional variant and small azurophilic granules in an acute promyelocytic leukemia case with NPM1/RARA fusion gene.
Kikuma T; Nakamachi Y; Noguchi Y; Okazaki Y; Shimomura D; Yakushijin K; Yamamoto K; Matsuoka H; Minami H; Itoh T; Kawano S
Int J Hematol; 2015 Dec; 102(6):713-8. PubMed ID: 26342691
[TBL] [Abstract][Full Text] [Related]
14. [Myeloidleukemia with external auditory canal granulocytic sarcoma: a case report].
Wang X; Mang R; Zhou Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jan; 29(1):91-3. PubMed ID: 25966566
[TBL] [Abstract][Full Text] [Related]
15. The PML-RARalpha fusion protein and targeted therapy for acute promyelocytic leukemia.
Jing Y
Leuk Lymphoma; 2004 Apr; 45(4):639-48. PubMed ID: 15160934
[TBL] [Abstract][Full Text] [Related]
16. A Rare Case of Relapsed Pediatric Acute Promyelocytic Leukemia with Skin Involvement by Myeloid Sarcoma.
Araújo NS; Dos Santos Júnior CJ; Gomes VMDS; Calheiros Leite LA; Bomfim LN; Gusmão AKFDS; Alves MJRG; Romão CMDSB; Batinga AMCS; da Silva MR; de Sousa Rodrigues CF
Am J Case Rep; 2018 Apr; 19():438-441. PubMed ID: 29650946
[TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide in the treatment of a patient with multiply recurrent, ATRA-resistant promyelocytic leukemia: a case report.
Bergstrom SK; Gillan E; Quinn JJ; Altman AJ
J Pediatr Hematol Oncol; 1998; 20(6):545-7. PubMed ID: 9856675
[TBL] [Abstract][Full Text] [Related]
18. Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group.
Adès L; Thomas X; Bresler AG; Raffoux E; Spertini O; Vey N; Marchand T; Récher C; Pigneux A; Girault S; Deconinck E; Gardin C; Tournilhac O; Lambert JF; Chevallier P; de Botton S; Lejeune J; Dombret H; Chevret S; Fenaux P
Haematologica; 2018 Dec; 103(12):2033-2039. PubMed ID: 30026341
[TBL] [Abstract][Full Text] [Related]
19. Arsenic but not all-trans retinoic acid overcomes the aberrant stem cell capacity of PML/RARalpha-positive leukemic stem cells.
Zheng X; Seshire A; Rüster B; Bug G; Beissert T; Puccetti E; Hoelzer D; Henschler R; Ruthardt M
Haematologica; 2007 Mar; 92(3):323-31. PubMed ID: 17339181
[TBL] [Abstract][Full Text] [Related]
20. Pulsed ATRA as single therapy restores long-term remission in PML-RARalpha-positive acute promyelocytic leukemia patients: real time quantification of minimal residual disease. A pilot study.
Visani G; Buonamici S; Malagola M; Isidori A; Piccaluga PP; Martinelli G; Ottaviani E; Grafone T; Baccarani M; Tura S
Leukemia; 2001 Nov; 15(11):1696-700. PubMed ID: 11681409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
